Gastroenterology. 2020 Apr 10;S0016-5085(20)30482-0.doi: 10.1053/j.gastro.2020.04.012. Online ahead of print.

David T Rubin ¹, Joseph D Feuerstein ², Andrew Y Wang ³, Russell D Cohen ⁴

Author information

¹University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL. Electronic address: drubin@uchicago.edu.

²Division of Gastroenterology and Center for Inflammatory Bowel Diseases, Beth Israel Deaconess Medical Center, Boston, MA.

³Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA.

⁴University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL.

Abstract

Description: The purpose of this AGA Institute Clinical Practice Update is to rapidly review the emerging evidence and provide timely expert recommendations regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic.

Methods: This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely perspective on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the CPUC and external peer review through standard procedures of Gastroenterology.